


	<meta http-equiv="content-type" content="text/html;charset=utf-8">
	<title>Zakon</title>
<link href="http://www.pravno-informacioni-sistem.rs/SlGlasnikPortal/glasnik.css" type="text/css" rel="stylesheet">
	<style type="text/css">
.auto-style1 {
	text-align: center;
}
</style>


	<div class="story">
				<p class="clan" style="font-weight: bold">Одлуке о сврставању робе које је донео Комитет 
				за Хармонизовани систем Светске царинске организације на 51. 
				заседању марта 2013. године</p>
				<p class="clan" style="margin-top: 0">"Службени гласник РС", број 60 од 10. јула 2013.</p>
				<p>На основу члана 3а став 4. Закона о Царинској тарифи („Службени гласник Републике Србије” бр. 62/05, 61/07 и 5/09) објављују се Одлуке о сврставању робе које је донео Комитет за Хармонизовани систем Светске царинске организације (у даљем тексту: СЦО) на свом 51. заседању марта 2013. године објављене на сајту СЦО 2013. године, а у складу са уговором потписаним између СЦО и Управе царина Републике Србије од 28. априла 2008. године, које у оригиналу на енглеском језику и у преводу на српски језик гласе:</p>
				<p>The following list contains the classification decisions (other than those subject to a reservation) taken by the Harmonized System Committee (51st Session – March 2013) on specific products, together with their related Harmonized System code numbers and, in certain cases, the classification rationale.</p>
				<p><span class="bold">Advice</span></p>
				<p>Parties seeking to import or export merchandise covered by a decision are advised to verify the implementation of the decision by the importing or exporting country, as the case may be.</p>
				<p>&nbsp;</p>
				<table class="tabela-sa-borderom">
					<tbody>
						<tr>
							<td class="bold">
								<p>No</p>
							</td>
							<td class="bold">
								<p>Product description</p>
							</td>
							<td class="bold" style="width: 15%">
								<p>Classification</p>
							</td>
							<td class="bold" style="width: 15%">
								<p>HS codes considered</p>
							</td>
							<td class="bold" style="width: 15%">
								<p>Classification rationale</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>1.</p>
							</td>
							<td>
								<p>Food preparation, consisting of, by weight, 81.8% skimmed milk, 7.7% rape oil, 7.7% sunflower-seed oil, 1.2% salt, 1% milk (whey) protein, 0.25% oat oil, 0.2% rennet, 0.1% acidifying culture, 0.05% colouring matter (beta-carotene) and 3.3 ^g vitamin D, obtained by mixing skimmed milk with vegetable oils and subsequent treatment by a bacterial culture and enzyme, coagulation, separation of casein, heating, pressing, forming, cutting and salting. Before consumption, the product has to be ripened for 7 to 10 weeks. The product is used as cheese substitute.</p>
							</td>
							<td class="auto-style1" style="width: 15%" valign="top">
								<p>1901.90</p>
							</td>
							<td class="auto-style1" style="width: 15%" valign="top">
								<p>04.06, 19.01 and 21.06</p>
							</td>
							<td class="auto-style1" style="width: 15%" valign="top">
								<p>GIRs 1 and 6.</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>2.</p>
							</td>
							<td>
								<p>A glass jar containing 200 g instant coffee and a decorated cup and saucer made of ceramic, put up for retail sale in a cardboard box.</p>
							</td>
							<td class="auto-style1" style="width: 15%" valign="top">
								<p>Separate Classification</p>
								<p>Instant coffee: 2101.11</p>
								<p>Cup and saucer: 69.12</p>
							</td>
							<td class="auto-style1" style="width: 15%" valign="top">
								<p>GIR 3 (b)</p>
							</td>
							<td class="auto-style1" style="width: 15%" valign="top">
								<p>GIRs 1 and 6. GIR 1.</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>3.</p>
							</td>
							<td>
								<p>Certain INN products.</p>
								<p>(See „INN List 106“ at the end of this</p>
								<p>publication.)</p>
							</td>
							<td class="auto-style1" style="width: 15%" valign="top">
								<p>Chapters 28, 29, 30, 35 and 39</p>
							</td>
							<td>
							</td>
							<td>
							</td>
						</tr>
						<tr>
							<td>
								<p>4.</p>
							</td>
							<td>
								<p>Certain INN products.</p>
								<p>(See „INN List 107“ at the end of this</p>
								<p>publication.)</p>
							</td>
							<td class="auto-style1" valign="top">
								<p>Chapters 28, 29, 30, 35 and 39</p>
							</td>
							<td>
							</td>
							<td>
							</td>
						</tr>
						<tr>
							<td>
								<p>5.</p>
							</td>
							<td>
								<p>Certain INN products. (See „Classification of „encaleret“ (INN list 105) and „trametinib“ (INN list 105)“ at the end of this publication.)</p>
							</td>
							<td class="auto-style1" valign="top">
								<p>Chapter 29</p>
							</td>
							<td>
							</td>
							<td>
							</td>
						</tr>
						<tr>
							<td>
								<p>6.</p>
							</td>
							<td>
								<p>Reclassification of certain INN products having the stem „morelin“ in their names. (See „Review of the classification of certain INN products having the stem ‚morelin‘“ at the end of this publication.)</p>
							</td>
							<td class="auto-style1" valign="top">
								<p>Chapter 29</p>
							</td>
							<td>
							</td>
							<td>
							</td>
						</tr>
						<tr>
							<td>
								<p>7.</p>
							</td>
							<td>
								<p>Reclassification of certain INN products having the stem „limus“ in their names, previously classified by their chemical structure.</p>
								<p>(See „Review of the classification of certain INN products having the stem ‚limus‘“ at the end of this publication.)</p>
							</td>
							<td class="auto-style1" valign="top">
								<p>Chapter 29</p>
							</td>
							<td>
							</td>
							<td>
							</td>
						</tr>
						<tr>
							<td>
								<p>8.</p>
							</td>
							<td>
								<p>Orlistat (INN) preparation (120 mg of orlistat per capsule) put up for retail sale in a plastic container holding 90 capsules. Apart from orlistat, each capsule contains : gelatine, indigo carmine (E132) and titanium dioxide (E171). The capsule shell contains (inactive ingredients) : microcrystalline cellulose, sodium starch glycollate, povidone, sodium lauryl sulphate and talc.</p>
								<p>The preparation should be administered in combination with a physician- supervised reduced-calorie diet. It is recommended as an effective long term tool for weight loss. Pooled data from clinical trials suggest that the effectiveness of orlistat in promoting weight loss is definite, though modest. The preparation can also help to improve risk factors, such as high blood pressure, high cholesterol, and high blood sugar, which, if not treated, could lead to other diseases such as hypertension and diabetes.</p>
							</td>
							<td class="auto-style1" valign="top">
								<p>3004.90</p>
							</td>
							<td class="auto-style1" valign="top">
								<p>21.06 and 30.04</p>
							</td>
							<td class="auto-style1" valign="top">
								<p>GIRs 1 and 6.</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>9.</p>
							</td>
							<td>
								<p>A split-system air conditioning machine consisting of :</p>
								<p>(i) a standing-type indoor unit, comprising a heat exchanger (evaporator) and a motor driven fan in a single housing. This unit is designed to be placed on the floor but usually not to be fixed tightly or set in concrete where it is located; and</p>
								<p>(ii) an outdoor unit, comprising a refrigerant type compressor, a heat exchanger (condenser) and a motor driven fan in a single housing. This unit is designed to be mounted or fixed on the ground or steel bars.</p>
								<p>Both units are designed to be connected to each other by electric wires and tubing through which refrigerant passes.</p>
							</td>
							<td class="auto-style1" valign="top">
								<p>8415.82</p>
							</td>
							<td class="auto-style1" valign="top">
								<p>8415.10 and 8415.82</p>
							</td>
							<td class="auto-style1" valign="top">
								<p>GIRs 1 and 6.</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>10.</p>
							</td>
							<td>
								<p>A portable self-contained air conditioning machine consisting of two motor driven fans, an evaporator, a condenser and a compressor in a single housing. The unit is mounted on four casters for ease of mobility and has two hand grips for shifting and moving. The unit can be attached with a flexible exhaust hose as an accessory for venting warm exhaust air through a window or wall.</p>
							</td>
							<td class="auto-style1" valign="top">
								<p>8415.82</p>
							</td>
							<td class="auto-style1" valign="top">
							&nbsp;</td>
							<td class="auto-style1" valign="top">
								<p>GIRs 1 and 6.</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>11.</p>
							</td>
							<td>
								<p>Steam turbine and AC electric generator presented together, but packed separately. The steam turbine spouts high-pressure heated steam and converts it into rotary motion of an output of 200 MV. The generator produces electrical power of an output of 230 MVA from the rotary motion of the steam turbine.</p>
								<p>These machines are designed to be mounted on the floor of an electric power generating facility, and the rotors of each are to be coupled together so that the two machines work in conjunction with each other to convert the thermal energy of pressurised steam into electric energy.</p>
							</td>
							<td class="auto-style1" valign="top">
								<p>8502.39</p>
							</td>
							<td class="auto-style1" valign="top">
								<p>Separate classification (84.06 and 85.02)</p>
							</td>
							<td class="auto-style1" valign="top">
								<p>GIRs 1 and 6.</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>12.</p>
							</td>
							<td>
								<p>Amplifier for musical instruments consisting of a class AB amplifier tube, two pre-amplifier tubes, two amplifier tubes and two loudspeakers, combined in a single housing. It accepts an electrical signal from variety of sources, such as an electric guitar, electronic keyboard/piano or an MP3 player, amplifies that signal and then produces sound by directing that amplified electrical signal to the loudspeakers. It can also modify the tone of that sound by emphasising or de-emphasising certain frequencies (bass, midrange and treble frequencies) and add certain electronic effects to the sound to be produced.</p>
							</td>
							<td class="auto-style1" valign="top">
								<p>8518.22</p>
							</td>
							<td class="auto-style1" valign="top">
								<p>8518.22, 8518.40 and 8518.50</p>
							</td>
							<td class="auto-style1" valign="top">
								<p>GIRs 1 and 6 (Note 3 to Section XVI).</p>
							</td>
						</tr>
					</tbody>
				</table>
				<p class="clan">CLASSIFICATION OF „ENCALERET“ (INN LIST 105) <br>AND „TRAMETINIB“ (INN LIST 105)</p>
				<table class="tabela-sa-borderom">
					<tbody>
						<tr>
							<td class="bold">
								<p>INN</p>
							</td>
							<td class="bold" style="width: 30%">
								<p>Classification</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>encaleret</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2922.19</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>trametinib</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.79</p>
							</td>
						</tr>
					</tbody>
				</table>
				<p class="clan">CLASSIFICATION OF INN PRODUCTS (LIST 106)</p>
				<table class="tabela-sa-borderom">
					<thead>
						<tr>
							<td class="bold">
								<p>INN</p>
							</td>
							<td class="bold" style="width: 30%">
								<p>Classification</p>
							</td>
						</tr>
					</thead>
					<tbody>
						<tr>
							<td>
								<p>deoxycholic acid</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2918.19</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>florilglutamic acid (18F)</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2844.40</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>tiazotic acid</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>amitifadine</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>bamosiran</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>brexpiprazole</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>buparlisib</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>camicinal</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.59</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>caplacizumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>cerlapirdine</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>dexmecamylamine</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2921.30</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>drisapersen</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>faldaprevir</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>flanvotumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>follitropin gamma</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2937.19</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>gemcitabine elaidate</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>glycerol phenylbutyrate</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2916.39</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>idursulfase beta</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3507.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>inclacumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>lucerastat</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.39</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>naltalimide</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>niraparib</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.39</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>ondelopran</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>patiromer calcium</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3906.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>patritumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>plazomicin</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2941.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>pradigastat</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.39</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>pritelivir</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2935.00</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>quilizumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>radavirsen</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>rafigrelide</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.59</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>refametinib</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2935.00</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>rigosertib</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2930.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>romosozumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>samidorphan</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.49</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>sapitinib</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.59</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>sarilumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>secretin human</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2937.19</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>selisistat</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>setrobuvir</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2935.00</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>sevuparin sodium</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3001.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>solitomab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>sovaprevir</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2935.00</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>sutezolid</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>tanzisertib</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>tavaborole</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>tedatioxetine</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.39</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>tipiracil</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.59</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>tirasemtiv</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>tozadenant</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.20</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>trebananib</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>trelagliptin</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.59</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>umeclidinium bromide</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.39</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>vapendavir</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>vonoprazan</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2935.00</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>vortioxetine</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.59</p>
							</td>
						</tr>
					</tbody>
				</table>
				<p class="clan">CLASSIFICATION OF INN PRODUCTS (LIST 107)</p>
				<table class="tabela-sa-borderom">
					<thead>
						<tr>
							<td>
								<p class="auto-style1"><b>INN</b></p>
							</td>
							<td style="width: 30%">
								<p class="auto-style1"><b>Classification</b></p>
							</td>
						</tr>
					</thead>
					<tbody>
						<tr>
							<td>
								<p>actoxumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>aladorian</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>alirocumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>antithrombin gamma</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>asudemotide</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.20</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>auriclosene</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2929.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>avatrombopag</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>balugrastim</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>baricitinib</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2935.00</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>bevenopran</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>bezlotoxumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>birinapant</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>blisibimod</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>burlulipase</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3507.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>cebranopadol</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>cindunistat</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2930.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>clazakizumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>cobimetinib</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.39</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>crisantaspase</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3507.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>dactolisib</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.49</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>danirixin</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.39</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>demcizumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>duligotumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>elubrixin</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2935.00</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>empegfilgrastim</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>enobosarm</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2926.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>enoticumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>ensereptide</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>enzalutamide</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.29</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>ertugliflozin</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2932.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>etirinotecan pegol</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2939.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>evogliptin</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.59</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>fasiglifam</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2932.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>fasinumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>firtecan pegol</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2939.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>fluralaner</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>futuximab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>giminabant</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.59</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>golvatinib</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.59</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>ibrutinib</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.59</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>idelalisib</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.59</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>imgatuzumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>insulin peglispro</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2937.19</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>lampalizumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>latanoprostene bunod</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2937.50</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>latromotide</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.20</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>lifitegrast</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>ligelizumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>lirilumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>lomibuvir</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>lucitanib</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.49</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>momelotinib</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>neceprevir</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2935.00</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>nivolumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>ocaratuzumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>omarigliptin</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2935.00</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>oprozomib</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>orticumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>parsatuzumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>perakizumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>placulumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>pocapavir</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2909.30</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>pradimotide</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.20</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>quisinostat</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.59</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>rabusertib</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>relugolix</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>rilimogene galvacirepvec</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>rilimogene glafolivec</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>saridegib</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2935.00</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>sebelipase alfa</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3507.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>senrebotase</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>simtuzumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>sonolisib</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2932.20</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>surotomycin</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2941.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>technetium (99mTc) etarfolatide</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2844.40</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>tenapanor</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2935.00</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>trabodenoson</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>trempamotide</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.20</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>trenonacog alfa</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>trifarotene</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>vercirnon</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2935.00</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>vintafolide</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2939.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>vocimagene amiretrorepvec</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>vorsetuzumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>vorsetuzumab mafodotin</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>zatuximab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>zoptarelin doxorubicin</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2941.90</p>
							</td>
						</tr>
					</tbody>
				</table>
				<p class="clan">REVIEW OF THE CLASSIFICATION OF CERTAIN <br>INN PRODUCTS HAVING THE STEM „MORELIN“</p>
				<table class="tabela-sa-borderom">
					<thead>
						<tr>
							<td class="bold">
								<p>INN</p>
							</td>
							<td class="bold" style="width: 30%">
								<p>Reviewed Classification</p>
							</td>
						</tr>
					</thead>
					<tbody>
						<tr>
							<td>
								<p>capromorelin (83)</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>examorelin (72)</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2937.19</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>macimorelin (100)</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2937.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>pralmorelin (77)</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2937.19</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>rismorelin (74)</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2937.19</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>sermorelin (56)</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2937.19</p>
							</td>
						</tr>
					</tbody>
				</table>
				<p class="clan">REVIEW OF THE CLASSIFICATION OF CERTAIN <br>INN PRODUCTS HAVING THE STEM „LIMUS“</p>
				<table class="tabela-sa-borderom">
					<tbody>
						<tr>
							<td class="bold">
								<p>INN</p>
							</td>
							<td class="bold" style="width: 30%">
								<p>Reviewed classification</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>everolimus (82)</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>pimecrolimus (81)</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
					</tbody>
				</table>
				<p>Copyright © 2013 World Customs Organization. All rights reserved. Requests and inquiries concerning translation, reproduction and adaptation rights should be addressed to copyright@wcoomd.org.</p>
				<p>Следећа листа садржи одлуке о сврставању робе (осим оних које су предмет захтева за поновно разматрање) које је донео Комитет за Хармонизовани систем (51. заседање – март 2013. године) за одређене производе, заједно са тарифном ознаком и, у одређеним случајевима, основом за сврставање (Основна правила за примењивање Царинске тарифе, у даљем тексту: ОПП).</p>
				<p><span class="bold">Савет:</span></p>
				<p>Чланицама које желе да увезу или извезу робу обухваћену одлуком, саветује се да провере да ли земља из које увозе или у коју извозе робу примењује одлуку, у зависности од случаја.</p>
				<table class="tabela-sa-borderom">
					<thead>
						<tr>
							<td>
								<p>Бр.</p>
							</td>
							<td class="bold">
								<p>Опис производа</p>
							</td>
							<td class="bold" style="width: 15%">
								<p>Сврставање</p>
							</td>
							<td class="bold" style="width: 15%">
								<p>Разматране тарифне ознаке</p>
							</td>
							<td class="bold" style="width: 15%">
								<p>Основ сврставања</p>
							</td>
						</tr>
					</thead>
					<tbody>
						<tr>
							<td>
								<p>1.</p>
							</td>
							<td>
								<p>Прехрамбени производ, који се састоји од, по маси, 81.8% обраног млека, 7.7% уља од репице, 7.7% уља од сунцокрета, 1.2% соли, 1% млечних (сурутка) беланчевина, 0.25% уља од овса, 0.2% сиришта, 0.1% културе за кисељење, 0.05% материје за бојење (бета каротен) и 3.3µg витамина D, добијен мешањем обраног млека са биљним уљима, и накнадним подвргавањем бактеријској култури и ензиму, коагулацијом, сепарацијом казеина, загревањем, пресовањем, обликовањем, сечењем и сољењем. Пре конзумације, производ мора да зри 7 до 10 седмица. Производ се употребљава као замена за сир.</p>
							</td>
							<td class="auto-style1" style="width: 15%" valign="top">
								<p>1901.90</p>
							</td>
							<td class="auto-style1" style="width: 15%" valign="top">
								<p>04.06, 19.01 и 21.06</p>
							</td>
							<td class="auto-style1" style="width: 15%" valign="top">
								<p>ОПП 1. и 6.</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>2.</p>
							</td>
							<td>
								<p>Тегла од стакла која садржи 200 g инстант кафе и декоративна шољица и тањирић израђени од керамике, припремљени за продају на мало у картонској кутији.</p>
							</td>
							<td class="auto-style1" style="width: 15%" valign="top">
								<p>Одвојено сврставање</p>
								<p>Инстант кафа: 2101.11</p>
								<p>Шољица и тањирић: 69.12</p>
							</td>
							<td class="auto-style1" style="width: 15%" valign="top">
								<p>ОПП 3(б) </p>
							</td>
							<td class="auto-style1" style="width: 15%" valign="top">
								<p>ОПП 1. и 6.</p>
								<p>ОПП 1.</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>3.</p>
							</td>
							<td>
								<p>Одређени INN производи.</p>
								<p>(Видети „INN листу 106” на крају ове публикације.)</p>
							</td>
							<td class="auto-style1" style="width: 15%" valign="top">
								<p>Главе 28, 29, 30, 35 и 39</p>
							</td>
							<td>
							</td>
							<td>
							</td>
						</tr>
						<tr>
							<td>
								<p>4.</p>
							</td>
							<td>
								<p>Одређени INN производи.</p>
								<p>(Видети „INN листу 107” на крају ове публикације.)</p>
							</td>
							<td class="auto-style1" style="width: 15%" valign="top">
								<p>Главе 28, 29, 30, 35 и 39</p>
							</td>
							<td>
							</td>
							<td>
							</td>
						</tr>
						<tr>
							<td>
								<p>5. </p>
							</td>
							<td>
								<p>Одређени INN производи.</p>
								<p>(Видети „Сврставање „encaleret” (INN листа 105) „trametinib” (INN листа 105)” на крају ове публикације.)</p>
							</td>
							<td class="auto-style1" style="width: 15%" valign="top">
								<p>Главa 29</p>
							</td>
							<td>
							</td>
							<td>
							</td>
						</tr>
						<tr>
							<td>
								<p>6.</p>
							</td>
							<td>
								<p>Поновно сврставање одређених INN производа којима је корен речи у називима „morelin”. (Видети „Review of the classificаtion of certain INN products having the stem „morelin” ” на крају ове публикације.)</p>
							</td>
							<td class="auto-style1" style="width: 15%" valign="top">
								<p>Главa 29</p>
							</td>
							<td>
							</td>
							<td>
							</td>
						</tr>
						<tr>
							<td>
								<p>7.</p>
							</td>
							<td>
								<p>Поновно сврставање одређених INN производа којима је корен речи у називима „limus”. (Видети „Review of the classificаtion of certain INN products having the stem „limus” ” на крају ове публикације.)</p>
							</td>
							<td class="auto-style1" style="width: 15%" valign="top">
								<p>Главa 29</p>
							</td>
							<td>
							</td>
							<td>
							</td>
						</tr>
						<tr>
							<td>
								<p>8.</p>
							</td>
							<td>
								<p>Орлистат (INN) препарат (120 mg орлистата по капсули) припремљен за продају на мало у пластичном контејнеру који садржи 90 капсула. Поред орлистата, свака капсула садржи: желатин, индиго кармин (Е 132) и титан диоксид (Е171). Опна капсуле садржи (неактивни састојци): микрокристалну целулозу, натријум скроб гликолат, повидон, натријум лаурил сулфат и талк.</p>
								<p>Препарат се уноси у комбинацији са калоријски редукованом дијетом, под надзором лекара. Препоручује се као ефикасно дугорочно средство за помоћ при губитку тежине. Прикупљени подаци из клиничких испитивања указују да је ефикасност орлистата у поспешивању губитка тежине неспорна, иако скромна. Препарат такође може да помогне у смањењу фактора ризика, као што су висок крвни притисак, висок холестерол, висок ниво шећера, који ако се не лече, могу да доведу до других болести као што су хипертензија и дијабетес.</p>
							</td>
							<td class="auto-style1" style="width: 15%" valign="top">
								<p>3004.90</p>
							</td>
							<td class="auto-style1" valign="top">
								<p>21.06 и 30.04</p>
							</td>
							<td class="auto-style1" valign="top">
								<p>ОПП 1. и 6.</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>9.</p>
							</td>
							<td>
								<p>Уређај за климатизацију типа „сплит-систем” састоји се од: </p>
								<p>(i) унутрашње јединице „стојећег” типа, која садржи измењивач топлоте (евапоратор) и вентилатор на моторни погон који су сви смештени у једном кућишту. Ова јединица је конструисана да се постави на под, али није уобичајено да буде чврсто фиксирана или уграђена у бетону где је постављена; и </p>
								<p>(ii) спољашње јединице која садржи компресор за хлађење, измењивач топлоте (кондензатор) и вентилатор на моторни погон у једном кућишту. Ова јединица је конструисана да се монтира или фиксира на земљу или челичне шипке.</p>
								<p>Обе јединице су конструисане да буду међусобно повезане електричним проводницима и цевима кроз које струји расхладно средство.</p>
							</td>
							<td class="auto-style1" style="width: 15%" valign="top">
								<p>8415.82</p>
							</td>
							<td class="auto-style1" valign="top">
								<p>8415.10 и 8415.82</p>
							</td>
							<td class="auto-style1" valign="top">
								<p>ОПП 1. и 6.</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>10.</p>
							</td>
							<td>
								<p>Преносива, самостална машина за климатизацију састоји се од два вентилатора на моторни погон, евапоратора, кондензатора и компресора у једном кућишту. Јединица је монтирана на четири точкића ради лакше покретљивости и има две ручке за окретање и померање. На јединицу може бити закачено савитљиво, издувно црево као прибор за избацивање топлог издувног ваздуха кроз прозор или зид.</p>
							</td>
							<td class="auto-style1" style="width: 15%" valign="top">
								<p>8415.82</p>
							</td>
							<td>
							</td>
							<td class="auto-style1" valign="top">
								<p>ОПП 1. и 6.</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>11.</p>
							</td>
							<td>
								<p>Парна турбина и генератор наизменичне струје испоручени заједно, али спаковани одвојено. Парна турбина избацује врелу пару под високим притиском и претвара је у ротационо кретање са излазном снагом од 200&nbsp;MW. Генератор производи електричну струју привидне снаге од 230&nbsp;MVА из ротационог кретања парне турбине.</p>
								<p>Ове машине су конструисане да се монтирају на поду постројења за добијање електричне енергије, а ротори сваке треба да се спрегну тако да две машине раде повезано једна са другом и претварају топлотну енергију паре под притиском у електричну енергију.</p>
							</td>
							<td class="auto-style1" style="width: 15%" valign="top">
								<p>8502.39</p>
							</td>
							<td class="auto-style1" valign="top">
								<p>Одвојено сврставање (84.06 и 85.02)</p>
							</td>
							<td class="auto-style1" valign="top">
								<p>ОПП 1. и 6.</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>12.</p>
							</td>
							<td>
								<p>Појачавач за музичке инструменте састоји се од појачавачке цеви класе AB, две предпојачавачке цеви, две појачавачке цеви и два звучника, комбинованих у јединственом кућишту. Он прима електрични сигнал из различитих извора, као што су електрична гитара, електронска клавијатура/клавир или MP3 плејер, појачава тај сигнал, а затим усмеравањем тог појачаног електричног сигнала до звучника, производи звук. Такође може да модификује тон тог звука појачавањем или смањивањем одређених фреквенција (бас, средње и врхове звучних фреквенција) ка и да дода одређене електронске ефекте звуку који производи.</p>
							</td>
							<td class="auto-style1" style="width: 15%" valign="top">
								<p>8518.22</p>
							</td>
							<td class="auto-style1" valign="top">
								<p>8518.22, 8518.40 и 8518.50</p>
							</td>
							<td class="auto-style1" valign="top">
								<p>ОПП 1. и 6.</p>
							</td>
						</tr>
					</tbody>
				</table>
				<p class="clan">СВРСТАВАЊЕ „ENCALERET” (INN Листа 105) <br>и „TRAMETINIB” (INN Листа 105)</p>
				<table class="tabela-sa-borderom">
					<tbody>
						<tr>
							<td class="bold">
								<p>INN</p>
							</td>
							<td class="bold" style="width: 30%">
								<p>Сврставање</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>encaleret </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2922.19</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>trametinib</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.79</p>
							</td>
						</tr>
					</tbody>
				</table>
				<p class="clan">СВРСТАВАЊЕ INN ПРОИЗВОДА (Листа 106)</p>
				<table class="tabela-sa-borderom">
					<thead>
						<tr>
							<td class="bold">
								<p>INN</p>
							</td>
							<td class="bold" style="width: 30%">
								<p>Сврставање</p>
							</td>
						</tr>
					</thead>
					<tbody>
						<tr>
							<td>
								<p>deoxycholic acid </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2918.19</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>florilglutamic acid (<span class="superscript">18</span>F) </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2844.40</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>tiazotic acid </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>amitifadine </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>bamosiran </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>brexpiprazole </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>buparlisib </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>camicinal </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.59</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>caplacizumab </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>cerlapirdine </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>dexmecamylamine </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2921.30</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>drisapersen </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>faldaprevir </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>flanvotumab </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>follitropin gamma </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2937.19</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>gemcitabine elaidate </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>glycerol phenylbutyrate </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2916.39</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>idursulfase beta </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3507.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>inclacumab </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>lucerastat </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.39</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>naltalimide </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>niraparib </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.39</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>ondelopran </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>patiromer calcium </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3906.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>patritumab </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>plazomicin </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2941.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>pradigastat </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.39</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>pritelivir </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2935.00</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>quilizumab </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>radavirsen </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>rafigrelide </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.59</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>refametinib </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2935.00</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>rigosertib </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2930.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>romosozumab </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>samidorphan </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.49</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>sapitinib </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.59</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>sarilumab </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>secretin human </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2937.19</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>selisistat </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>setrobuvir </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2935.00</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>evuparin sodium </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3001.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>solitomab </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>sovaprevir </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2935.00</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>sutezolid </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>tanzisertib </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>tavaborole </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>tedatioxetine </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.39</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>tipiracil </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.59</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>tirasemtiv </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>tozadenant </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.20</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>trebananib </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>trelagliptin </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.59</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>umeclidinium bromide </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.39</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>vapendavir </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>vonoprazan </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2935.00</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>vortioxetine</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.59</p>
							</td>
						</tr>
					</tbody>
				</table>
				<p class="clan">СВРСТАВАЊЕ INN ПРОИЗВОДА (Листа 107)</p>
				<table class="tabela-sa-borderom">
					<thead>
						<tr>
							<td class="bold">
								<p>INN</p>
							</td>
							<td class="bold" style="width: 30%">
								<p>Сврставање</p>
							</td>
						</tr>
					</thead>
					<tbody>
						<tr>
							<td>
								<p>actoxumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>aladorian</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>alirocumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>antithrombin gamma</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>asudemotide</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.20</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>auriclosene</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2929.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>avatrombopag</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>balugrastim</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>baricitinib</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2935.00</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>bevenopran</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>bezlotoxumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>birinapant</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>blisibimod</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>burlulipase</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3507.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>cebranopadol</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>cindunistat</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2930.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>clazakizumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>cobimetinib</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.39</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>crisantaspase</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3507.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>dactolisib</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.49</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>danirixin</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.39</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>demcizumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>duligotumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>elubrixin</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2935.00</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>empegfilgrastim</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>enobosarm</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2926.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>enoticumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>ensereptide</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>enzalutamide</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.29</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>ertugliflozin</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2932.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>etirinotecan pegol</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2939.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>evogliptin</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.59</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>fasiglifam</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2932.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>fasinumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>firtecan pegol</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2939.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>fluralaner</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>futuximab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>giminabant</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.59</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>golvatinib</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.59</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>ibrutinib</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.59</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>idelalisib</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.59</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>imgatuzumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>insulin peglispro</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2937.19</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>lampalizumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>latanoprostene bunod</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2937.50</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>latromotide</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.20</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>lifitegrast</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>ligelizumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>lirilumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>lomibuvir</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>lucitanib</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.49</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>momelotinib</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>neceprevir</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2935.00</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>nivolumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>ocaratuzumab</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>omarigliptin </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2935.00</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>oprozomib </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>orticumab </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>parsatuzumab </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>perakizumab </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>placulumab </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>pocapavir </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2909.30</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>pradimotide </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.20</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>quisinostat </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.59</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>rabusertib </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>relugolix </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>rilimogene galvacirepvec </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>rilimogene glafolivec </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>saridegib </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2935.00</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>sebelipase alfa </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3507.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>senrebotase </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>simtuzumab </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>sonolisib </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2932.20</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>surotomycin</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2941.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>technetium (99mTc) etarfolatide </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2844.40</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>tenapanor </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2935.00</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>trabodenoson </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>trempamotide </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.20</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>trenonacog alfa </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>trifarotene </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>vercirnon </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2935.00</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>vintafolide </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2939.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>vocimagene amiretrorepvec </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>vorsetuzumab </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>vorsetuzumab mafodotin </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>zatuximab </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>3002.10</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>zoptarelin doxorubicin </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2941.90</p>
							</td>
						</tr>
					</tbody>
				</table>
				<p class="clan">ПРЕГЛЕД СВРСТАВАЊА ОДРЕЂЕНИХ INN ПРОИЗВОДА<br>којима је корен речи у називима „MORELIN”</p>
				<table class="tabela-sa-borderom">
					<tbody>
						<tr>
							<td class="bold">
								<p>INN</p>
							</td>
							<td class="bold" style="width: 30%">
								<p>Прегледано сврставање</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>capromorelin (83) </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2933.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>examorelin (72) </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2937.19</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>macimorelin (100) </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2937.90</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>pralmorelin (77) </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2937.19</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>rismorelin (74) </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2937.19</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>sermorelin (56) </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2937.19</p>
							</td>
						</tr>
					</tbody>
				</table>
				<p class="clan">ПРЕГЛЕД СВРСТАВАЊА ОДРЕЂЕНИХ INN ПРОИЗВОДА <br>којима је корен речи у називима „LIMUS”</p>
				<table class="tabela-sa-borderom">
					<tbody>
						<tr>
							<td class="bold">
								<p>INN</p>
							</td>
							<td class="bold" style="width: 30%">
								<p>Прегледано сврставање</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>everolimus (82) </p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
						<tr>
							<td>
								<p>pimecrolimus (81)</p>
							</td>
							<td class="auto-style1" style="width: 30%">
								<p>2934.99</p>
							</td>
						</tr>
					</tbody>
				</table>
				<p><span class="italik">Оригинално објављено од стране СЦО на енглеском и француском под насловима:</span></p>
				<p><span class="bold">Harmonized System Committee Decisions</span></p>
				<p><span class="bold">http://www.wcoomd.org/ie/en/en.html</span></p>
				<p><span class="bold">Décisions du Comité du Systéme Harmonisé</span></p>
				<p><span class="bold">http://www.wcoomd.org/ie/fr/fr.html</span></p>
				<p>© <span class="italik">2013. година, Светска царинска организација (СЦО), Брисел, Белгија</span></p>
				<p><span class="italik">Сва права задржана</span></p>
				<p>© <span class="italik">Управа царина Републике Србије, јун 2013. година за издање из јуна 2013. године</span></p>
				<p><span class="italik">Објављено споразумно са СЦО, Брисел, Белгија</span></p>
				<p><span class="italik">Квалитет овог превода и његова повезаност са службеним текстом су одговорност Управе царина Републике Србије.</span></p>
				<p><span class="italik">Управа царина наводи да су само француска и енглеска верзија службене и могу се користити као референтне.</span></p>
	</div>

